These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8249381)

  • 61. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E; Bosch-Perez A
    Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical experience with aztreonam in the treatment of gram-negative bacteremia.
    Scully BE; Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S789-93. PubMed ID: 3909338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical experience with aztreonam in four Mediterranean countries.
    Daikos GK
    Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics of aztreonam and imipenem in critically ill patients with pneumonia.
    McKindley DS; Boucher BA; Hess MM; Croce MA; Fabian TC
    Pharmacotherapy; 1996; 16(5):924-31. PubMed ID: 8888088
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
    Simons WJ; Lee TJ
    Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: a perspective from the study of catheter biofilms.
    Stickler DJ
    Symp Ser Soc Appl Microbiol; 2002; (31):163S-170S. PubMed ID: 12481841
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of the febrile neutropenic patient.
    Picazo JJ;
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gram-negative bacterial resistance: evolving patterns and treatment paradigms.
    Kollef MH
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S85-8. PubMed ID: 15712101
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli.
    Donskey CJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S62-9. PubMed ID: 16894517
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
    Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
    Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aztreonam/clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients: case reports.
    García Sánchez JE; Vazquez López ML; Blazquez de Castro AM; Perez Simon JA; Gutierrez NG; Martin IT; García-Rodríguez JA
    J Chemother; 1997 Jun; 9(3):238-40. PubMed ID: 9210009
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Single versus combined antibiotic therapy for gram-negative infections.
    Klibanov OM; Raasch RH; Rublein JC
    Ann Pharmacother; 2004 Feb; 38(2):332-7. PubMed ID: 14742774
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit.
    Toltzis P
    Minerva Pediatr; 2003 Oct; 55(5):385-93. PubMed ID: 14608262
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
    Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infections.
    Capitano B; Nicolau DP; Potoski BA; Byers KE; Horowitz M; Venkataramanan R; Paterson DL
    Pharmacotherapy; 2004 Jun; 24(6):803-7. PubMed ID: 15222672
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aztreonam: the first monobactam antibiotic.
    Stutman HR
    Pediatr Infect Dis J; 1987 Jun; 6(6):550-5. PubMed ID: 3302907
    [No Abstract]   [Full Text] [Related]  

  • 80. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
    Marco V; Gobernado M; Santos M; Rabinad E
    Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.